Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

Autor:	Tauber, E., Kollaritsch, H., Von Sonnenburg, F., Lademann, M., Jilma, B., Firbas, C., Jelinek, T., Beckett, C., Knobloch, J., McBride, W. J. H., Schuller, E., Kaltenböck, A., Sun, W., Lyons, A.
Zdroj:	The Journal of Infectious Diseases, 2008 Aug . 198(4), 493-499.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/40254063 Zobrazit plný text záznamu